These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36455524)

  • 21. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke.
    Gonzalez JB; Testai FD
    Neurol Clin; 2021 Feb; 39(1):51-69. PubMed ID: 33223089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source.
    Ntaios G; Perlepe K; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Koroboki E; Manios E; Makaritsis K; Vemmos K; Michel P
    J Am Heart Assoc; 2019 Aug; 8(15):e012858. PubMed ID: 31364451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
    Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique Clinicopathologic Subclassifiers of Cryptogenic Cerebral Emboli.
    Siegler JE; Thau L; Hester T; Yeager T; Vigilante N; Kamen S; Heslin M; Shannon R; Zhang L; Butler M; Higham C; Oak S; Wolfe J; Patel P; Patel P; Thon JM
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106427. PubMed ID: 35279004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of transesophageal echocardiography combined with contrast transthoracic echocardiography for embolic stroke of undetermined source.
    Huang W; Wang H
    Perfusion; 2023 Sep; ():2676591231198356. PubMed ID: 37657946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
    Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
    Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Patent Foramen Ovale in North Indian Cryptogenic Young Strokes.
    Khurana D; Petluri G; Kumar M; Bahl A; Kumar A; Gairolla J; Prabhakar S
    Neurol India; 2022; 70(3):1077-1082. PubMed ID: 35864642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
    Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
    JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patent foramen ovale in embolic stroke of undetermined source patients: Malaysian experts' consensus.
    Albart SA; Yusof Khan AHK; Wan Zaidi WA; Muthuppalaniappan AM; Kandavello G; Koh GT; Leong MC; Liew HB; Ong BH; Viswanathan S; Hoo FK; Looi I; Yap YG; Law WC
    Med J Malaysia; 2023 May; 78(3):389-403. PubMed ID: 37271850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial cardiopathy in young adults with embolic stroke of undetermined source: a myocardial deformation imaging analysis.
    Pires CM; Silva R; Garcia BL; Antunes N; Vieira C; Marques J; Queirós S; Pereira VH
    Int J Cardiovasc Imaging; 2023 Apr; 39(4):737-746. PubMed ID: 36542217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Embolic Sources Differ in Patients With Embolic Stroke of Undetermined Source According to Age: A 15-Year Study.
    Hou Y; Elmashad A; Staff I; Alberts M; Nouh A
    Front Neurol; 2022; 13():860827. PubMed ID: 35655618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical RoPE (cRoPE) score predicts patent foramen ovale detection among stroke patients: a multicenter observational study.
    Giannandrea D; Padiglioni C; Eusebi P; Mengoni A; Romoli M; Galati F; Vecchio A; Cenciarelli S; Ricci S; Consoli D;
    Neurol Sci; 2020 Nov; 41(11):3227-3233. PubMed ID: 32388644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of patent foramen ovale location with severity of stroke: A new risk factor for paradoxical embolism.
    Erkoç MF; Öztoprak B; Okur A; Ede H; Örsçelik Ö; Kantarcı M; Kızrak Y
    Acta Clin Belg; 2016 Jun; 71(3):149-53. PubMed ID: 27075798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal arterial occlusion and patent foramen ovale: A case study-based review.
    Fekri S; Mahmoudimehr P; Jafari Fesharaki M; Hosseinjani E; Abtahi SH; Nouri H
    J Fr Ophtalmol; 2024 Jan; 47(1):104021. PubMed ID: 37951744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of D-dimer for pathologic differentiation on transesophageal echocardiography in embolic stroke of undetermined source: a single-center experience.
    Hira K; Ueno Y; Watanabe M; Shimura H; Kurita N; Miyamoto N; Haginiwa H; Yamashiro K; Hattori N; Urabe T
    BMC Neurol; 2022 Sep; 22(1):338. PubMed ID: 36076175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
    Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.